Literature DB >> 2006018

Multiple sclerosis and narcolepsy: possible similar genetic susceptibility.

D S Younger1, T A Pedley, M J Thorpy.   

Abstract

We have studied 2 patients with multiple sclerosis and narcolepsy. In both patients, the DR 2 histocompatibility antigen was positive. In each of the patients, the diagnosis of narcolepsy was confirmed by polygraphic testing.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2006018     DOI： 10.1212/wnl.41.3.447

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  6 in total

1.  Effect of eszopiclone on sleep disturbances and daytime fatigue in multiple sclerosis patients.

Authors:  Hrayr Attarian; Garrick Applebee; Angela Applebee; Bingxia Wang; Melissa Clark; Becky McCormick; Emma Salzman; Catherine Schuman
Journal:  Int J MS Care       Date:  2011

Review 2.  Sleep disorders in multiple sclerosis. Review.

Authors:  Christian Veauthier
Journal:  Curr Neurol Neurosci Rep       Date:  2015-05       Impact factor: 5.081

Review 3.  Fatigue in multiple sclerosis: a rational approach to evaluation and treatment.

Authors:  Jay H Rosenberg; Renata Shafor
Journal:  Curr Neurol Neurosci Rep       Date:  2005-03       Impact factor: 5.081

4.  Fatigue, sleep disturbances and circadian rhythm in multiple sclerosis.

Authors:  M J Taphoorn; E van Someren; F J Snoek; R L Strijers; D F Swaab; F Visscher; L P de Waal; C H Polman
Journal:  J Neurol       Date:  1993-07       Impact factor: 4.849

5.  Anesthesia in multiple sclerosis and obstructive sleep apnea: case report and literature review.

Authors:  Aysegul Ceyhan; Esra Turkyilmaz Uyar; Isin Yazici Gencay; Solmaz Eruyar Gunal
Journal:  J Res Med Sci       Date:  2011-06       Impact factor: 1.852

6.  Comorbidity of Narcolepsy Type 1 With Autoimmune Diseases and Other Immunopathological Disorders: A Case-Control Study.

Authors:  Francisco Javier Martinez-Orozco; Jose Luis Vicario; Clara De Andres; Miguel Fernandez-Arquero; Rosa Peraita-Adrados
Journal:  J Clin Med Res       Date:  2016-05-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.